摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,4:3,6-dianhydro-D-sorbitol-2,5-bis(4-acetoxybenzoate) | 1337985-51-9

中文名称
——
中文别名
——
英文名称
1,4:3,6-dianhydro-D-sorbitol-2,5-bis(4-acetoxybenzoate)
英文别名
[(3S,3aR,6R,6aR)-6-(4-acetyloxybenzoyl)oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl] 4-acetyloxybenzoate
1,4:3,6-dianhydro-D-sorbitol-2,5-bis(4-acetoxybenzoate)化学式
CAS
1337985-51-9
化学式
C24H22O10
mdl
——
分子量
470.433
InChiKey
FXWINTKOHKQNIN-CIAFKFPVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    34
  • 可旋转键数:
    10
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    124
  • 氢给体数:
    0
  • 氢受体数:
    10

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,4:3,6-dianhydro-D-sorbitol-2,5-bis(4-acetoxybenzoate) 在 sodium hydroxide 、 盐酸 作用下, 以 乙醇 为溶剂, 反应 2.0h, 以87%的产率得到2,5-双缩山梨醇-双-4-羟基苯甲酸酯
    参考文献:
    名称:
    Tuning Helical Twisting Power of Isosorbide-Based Chiral Dopants by Chemical Modifications
    摘要:
    Isosorbide-based chiral dopants (ICD) with various substituent groups were newly synthesized to control their helical twisting powers (HTP). Phase transition behaviors of ICD molecules were first investigated by combined techniques of differential scanning calorimetry, wide-angle X-ray diffraction, and cross-polarized optical microscopy. ICD with n-hexyloxy end groups formed the multiple ordered phases, and those with methoxy or acetoxy end groups exhibited a simple crystal-to-isotropic transition. Energy-minimized chemical conformations of ICD molecules revealed that all the ICDs had twisted conformations and that the extension of the benzoyl ester moiety induced a higher twisted conformation. By varying substitution groups, HTPs of ICDs were controlled from 26.6 to 80.2m-1. Particularly, ICD with an acetoxy end group (ICD-2) showed the largest HTP. It was also realized that by controlling the content of ICD-2 from 3.0 to 4.5mol%, the helical pitch length of cholesteric LC mixture was adjusted to reflect a specific visible light.
    DOI:
    10.1080/15421406.2010.526523
  • 作为产物:
    描述:
    参考文献:
    名称:
    Tuning Helical Twisting Power of Isosorbide-Based Chiral Dopants by Chemical Modifications
    摘要:
    Isosorbide-based chiral dopants (ICD) with various substituent groups were newly synthesized to control their helical twisting powers (HTP). Phase transition behaviors of ICD molecules were first investigated by combined techniques of differential scanning calorimetry, wide-angle X-ray diffraction, and cross-polarized optical microscopy. ICD with n-hexyloxy end groups formed the multiple ordered phases, and those with methoxy or acetoxy end groups exhibited a simple crystal-to-isotropic transition. Energy-minimized chemical conformations of ICD molecules revealed that all the ICDs had twisted conformations and that the extension of the benzoyl ester moiety induced a higher twisted conformation. By varying substitution groups, HTPs of ICDs were controlled from 26.6 to 80.2m-1. Particularly, ICD with an acetoxy end group (ICD-2) showed the largest HTP. It was also realized that by controlling the content of ICD-2 from 3.0 to 4.5mol%, the helical pitch length of cholesteric LC mixture was adjusted to reflect a specific visible light.
    DOI:
    10.1080/15421406.2010.526523
点击查看最新优质反应信息

文献信息

  • Bio-based chiral dopants having an isohexide skeleton for cholesteric liquid crystal materials
    作者:Seunghan Shin、Jae Won Seo、Jin Ku Cho、Sangyong Kim、Jaeryung Cha、Myoung Seon Gong
    DOI:10.1039/c2gc16261j
    日期:——
    synthesized from bio-based epimeric isohexides (glucose-derived isosorbide and mannose-derived isomannide) and their phase transition behaviors and abilities for developing cholesteric liquid crystal (CLC) films were examined with a consideration of the core structure. In spite of lower reactivity of the endo hydroxy group of isomannide caused by the steric hindrance and intermolecular hydrogen bonding
    手性掺杂剂是由基于生物的差向异构异己酸酯合成的(葡萄糖-衍生的 异山梨醇甘露糖-衍生的 异甘露糖苷),并考虑了其核心结构,研究了它们的相变行为和形成胆甾型液晶(CLC)膜的能力。尽管其内羟基的反应性较低异甘露糖苷 由位阻和分子间氢键引起的,带有异甘露糖苷核的手性掺杂剂的最终合成产率(IH-2为64.5%,IH-4为65.0%)与带有手性掺杂剂的手性掺杂剂相比没有明显的差异。 异山梨醇(IH-1为68.4%,IH-3为74.0%)。另一方面,在相变行为中,尽管具有相同的取代基,但带有异甘露糖苷核的手性掺杂剂的结晶和熔融温度却低于IH-1,IH-3。手性掺杂剂的螺旋扭转力(HTP)异山梨醇 (IH-1和IH-3)高于手性掺杂剂 异甘露糖苷(IH-2和IH-4)。IH-1和III-3所计算的高毒农药为26.6和42.1微米-1,分别。在IH-3的情况下,可以通过控制CLC的量来调整CLC的螺旋节距长度以反射可见光,并在5
查看更多

同类化合物

顺式-2,3,3a,6a-四氢呋喃[2,3-b]呋喃 莱克酮 索尼地平 硝酸异山梨酯 溴化二氢6-(联苯基-4-基)-3-氯-12,13-二甲氧基-9,10--7H-异奎并[2,1-d][1,4]苯并二氮卓-8-正离子 星形曲霉毒素 抗坏血酸原 A 异山梨醇二甲基醚 异山梨醇13C65-单酸酯 异山梨醇 失水甘露醇单油酸酯 失水甘露醇单油酸酯 大青素 地瑞那韦中间体1 四氢呋喃[2,3-B]呋喃-2(6AH)-酮 四氢-6a-甲基-呋喃并[2,3-b]呋喃-2(3H)-酮 四氢-6-硫代-1,4-乙桥-1H,3H-呋喃并(3,4-c)呋喃-3-酮 去甲斑蝥素 单硝酸异山梨酯杂质C 单-9-十八烯酸1,4:3,6-双脱水-D-甘露醇酯 华北白前甙元B 六氢呋喃并[2,3-b]呋喃-3-醇 六氢呋喃并[2,3-b]呋喃 六氢-呋喃并[2,3-b]呋喃-3-醇 克罗拉滨杂质7 二氯萘 二氢-1,4-二甲基-1,4-乙桥-1H,3H-呋喃并(3,4-c)呋喃-3,6(4H)-二酮 二氢-1,4-乙桥-1H,3H-呋喃并(3,4-c)呋喃-3,6(4H)-二酮 二氢-1,4-乙桥-1H,3H-呋喃并(3,4-c)呋喃-3,6(4H)-二硫酮 乙酸异山梨醇酯 丙氨酸,N-(5-氯-2-羟基苯甲酰)- N-乙酰基-L-丙氨酰-L-酪氨酸 L-葡糖酸-3,6-内酯 D-葡糖醛酸-γ-内酯丙酮化合物 D-甘露呋喃糖醛酸 gamma-内酯 BISTHFHNS衍生物3 7H,10H-呋喃并[2,3,4-cd]萘并[2,1-e]异苯并呋喃-7-酮,十四氢-10-羟基-1,1,4a-三甲基-,(4aS,4bR,6aR,8aR,10R,10aS,10bR,12aS)-(9CI) 7-氧杂二环[2.2.1]庚-5-烯-2,3-二羧酸酐 6H,9H-苯并[e]呋喃并[2,3,4-cd]异苯并呋喃-6-酮,2,4,4a,5,7,8,10a,10b-八氢-5,5-二甲基-,(4aR,8aR,10aR,10bS)-(9CI) 6-[(1E,3E,5E)-6-[(1R,2R,3R,5R,7R,8R)-7-乙基-2,8-二羟基-1,8-二甲基L-4,6-二氧杂双环[3.3.0]辛-3-基]己-1,3,5-三烯基]-4-甲氧基-5-甲基-吡喃-2-酮 5-单硝酸异山梨酯 5-乙酸异山梨酯 5-乙酸异山梨酯 5-[(4,6-二氯-1,3,5-三嗪-2-基)氨基]-4-羟基-3-[(4-磺酸根-1-萘基)偶氮]萘-2,7-二磺化三钠 5,6-二溴-7-氧杂双环[2.2.1]庚烷-2,3-二甲酸酐 5,5-二甲基-4,8-二氧杂三环[4.2.1.03,7]壬-2-基丙烯酸酯 4-硝基苯并[pqr]四苯-1-醇 4,10-二氧杂三环[5.2.1.0(2,6)]癸-8-烯-3-酮 4,10-二氧杂三环[5.2.1.0(2,6)]癸-8-烯-3,5-二酮 3-脱氧-14,15-二氢-15-羟基-莸酯素醇